J Epidemiol Community Health

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Epidemiology and Community Health 2007;61:578-584; doi:10.1136/jech.2006.051375
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davaalkham, D.
Right arrow Articles by Nakamura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davaalkham, D.
Right arrow Articles by Nakamura, Y.
Topic Collections
Right arrowRelated Article

EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE

Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nationwide survey

Dambadarjaa Davaalkham1, Toshiyuki Ojima1, Steven Wiersma2, Tserenkhuu Lkhagvasuren3, Pagvajav Nymadawa4, Ritei Uehara1, Makoto Watanabe1, Izumi Oki1, Yosikazu Nakamura1

1 Department of Public Health, Jichi Medical University School of Medicine, Tochigi, Japan
2 Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
3 Health Sciences University, Ulaanbaatar, Mongolia
4 National Center for Communicable Diseases, Ulaanbaatar, Mongolia

Correspondence to:
Correspondence to:
Dr D Davaalkham
Department of Public Health, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan; davaamon{at}jichi.ac.jp

Background: Universal hepatitis B (HB) immunisation is the most effective means for prevention of hepatitis B virus (HBV) infection worldwide. Maintaining the vaccine cold chain is an essential part of a successful immunisation programme. Our recent nationwide survey in Mongolia has observed significant urban–rural differences in the prevalence of HBV infection among vaccinated cohorts.

Objective: To examine whether the administration of HB vaccine in winter contributes to these residential discrepancies on the effectiveness of vaccination.

Design and setting: In 2004, a nationwide serosurvey was carried out covering both urban and rural areas of Mongolia. Sampling was multistage, with random probability from all public schools in the country.

Participants: A random sample of 1145 children (51.7% boys; aged 7–12 years), representative of Mongolian elementary school children.

Results: Multivariate logistic regression analysis identified that total (past and current) HBV infection (OR 2.31, 95% CI 1.20 to 4.42; p = 0.012) was independently associated with the administration of all HB vaccines in winter. An increased OR for current HBV infection was also observed (OR 2.58, 95% CI 0.87 to 7.68; p = 0.089), but without significance. Interestingly, after stratifying by residence, the association between winter vaccination and total HBV infection was evident for rural (p = 0.008) but not for urban areas (p = 0.294). The frequency of vaccine-induced immunity was significantly (p = 0.007) lower for those who received HB vaccine at birth during winter in rural areas.

Conclusion: Administration of HB vaccine during winter is an important predictor of the low effectiveness of vaccination in rural Mongolia. To improve the effectiveness of HB vaccination in remote areas, cold chain control should be addressed with particular attention to the winter season.


Abbreviations: anti-HBc, antibody against hepatitis B core antigen; anti-HBs, antibody to hepatitis B surface antigen; EPI, Expanded Program on Immunization; HB, hepatitis B; HbsAg, hepatitis B surface antigen; HBV, hepatitis B virus; WHO, World Health Organization


Related Article

In this issue
Carlos Alvarez-Dardet and John R Ashton
J. Epidemiol. Community Health 2007 61: 561. [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.